ArticleJAMA oncology2019

Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.

Nora Pashayan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.